Researchers build database to track APS and lupus patients

NCT ID NCT02782039

Completed Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study created a registry to collect medical information from 868 people with Anti-Phospholipid Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE). The goal was to gather data on these conditions, not to test a new treatment. Participants were adults diagnosed with APS or SLE.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTI-PHOSPHOLIPIDS SYNDROME (APS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

antiphospholipid syndrome systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTI-PHOSPHOLIPIDS SYNDROME (APS) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Contacts and locations

Locations

Hôpital Claude Huriez

Lille, 59000, France
Hôpital Cochin

Paris, PARIS, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.